Abstract

The liver is important for protein synthesis, detoxification, and amino acid metabolism. Nitric oxide (NO) is a key mediator in hepatocyte proliferation during liver regeneration. It is an oxidative metabolite of L-arginine produced by enzymes called nitric oxide synthase. The aim of this study is to evaluate the effect of Larginine on the liver functions of patients with liver disorders and to explore the role of L-arginine in the pathogenesis of the liver. The biochemical tests of the liver like ALT, AST, and ALP were done in the groups. The treatment with L-arginine as a test drug showed a significant decrease in the levels of biochemical markers to the nearnormal levels. The study concluded that the treatment with formulations containing Larginine helped in regaining the normal hepatic architecture.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.